Search results for " ARTE"

showing 10 items of 8496 documents

Phosphodiesterase-5 Inhibition Alleviates Pulmonary Hypertension and Basal Lamina Thickening in Rats Challenged by Chronic Hypoxia

2018

javax.xml.bind.JAXBElement@6f8948ff Hypoxia represents both an outcome of cardiopulmonary diseases and a trigger for severe pulmonary complications as pulmonary hypertension. Because nitric oxide (NO) is a critical mediator in the development of pulmonary hypertension, the modulators of its downstream function may become target of pharmacological interventions aimed at alleviating the impact of this condition. Here, we investigate the effects of an early administration of phosphodiesterase-5 inhibitor in rats where pulmonary artery hypertension was induced by chronic exposure to hypoxia. javax.xml.bind.JAXBElement@162dc677 Rats were divided into three groups: normoxic control, hypoxic with …

0301 basic medicinemedicine.medical_specialtynitrites and nitratesPhysiologySildenafilsildenafil030204 cardiovascular system & hematologyphosphodiesterase 5lcsh:PhysiologyNitric oxideendothelial NO synthase; nitric oxide; nitrites and nitrates; phosphodiesterase 5; pulmonary hypertension; pulmonary vascular remodeling; right heart failure; sildenafil03 medical and health scienceschemistry.chemical_compound0302 clinical medicinenitric oxidePhysiology (medical)medicine.arteryInternal medicinepulmonary hypertensionmedicineendothelial NO synthaseOriginal ResearchCardiopulmonary diseaseLunglcsh:QP1-981business.industryright heart failureHypoxia (medical)medicine.diseasePulmonary hypertension030104 developmental biologymedicine.anatomical_structurechemistryVentriclePulmonary arteryCardiologymedicine.symptombusinesspulmonary vascular remodelingFrontiers in Physiology
researchProduct

New insights about the putative role of myokines in the context of cardiac rehabilitation and secondary cardiovascular prevention.

2017

Exercise training prevents the onset and the development of many chronic diseases, acting as an effective tool both for primary and for secondary prevention. Various mechanisms that may be the effectors of these beneficial effects have been proposed during the past decades: some of these are well recognized, others less. Muscular myokines, released during and after muscular contraction, have been proposed as key mediators of the systemic effects of the exercise. Nevertheless the availability of an impressive amount of evidence regarding the systemic effects of muscle-derived factors, few studies have examined key issues: (I) if skeletal muscle cells themselves are the main source of cytokin…

0301 basic medicinemedicine.medical_specialtyregular exercisemedicine.medical_treatmentInflammationBioinformaticsCachexiaCoronary artery disease03 medical and health sciencesMyokineMyokineReview Article on Myokines Exercise and Cardiovascular DiseasemedicineRehabilitationMyokines; cardiac rehabilitation; cardiovascular disease (CVD); cerebrovascular disease; regular exercisecardiovascular disease (CVD)business.industrySkeletal muscleGeneral Medicinemedicine.diseasecerebrovascular diseasecardiac rehabilitation030104 developmental biologyCytokinemedicine.anatomical_structureSarcopeniaPhysical therapymedicine.symptombusiness
researchProduct

European contribution to the study of ROS : A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)

2017

WOS: 000410470000009

0301 basic medicinereactive oxygen species ; reactive nitrogen species ; redox signaling ; oxidative stress ; antioxidants ; redox therapeuticsRedox signalingInternational CooperationSMOOTH-MUSCLE-CELLS[SDV]Life Sciences [q-bio]Clinical BiochemistryISCHEMIA-REPERFUSION INJURYReviewddc:616.07Bioinformaticsmedicine.disease_causeBiochemistryAntioxidants0302 clinical medicineENDOPLASMIC-RETICULUM STRESSCost actionlcsh:QH301-705.5ComputingMilieux_MISCELLANEOUSmedia_commonlcsh:R5-920Redox therapeuticsReactive nitrogen species3. Good healthVariety (cybernetics)MANGANESE SUPEROXIDE-DISMUTASECHRONIC GRANULOMATOUS-DISEASERisk analysis (engineering)ddc:540lcsh:Medicine (General)Oxidation-ReductionSignal TransductionSocieties ScientificPULMONARY ARTERIAL-HYPERTENSIONMedicinaEstrès oxidatiuBiology03 medical and health sciencesAntioxidants ; Oxidative Stress ; Reactive Nitrogen Species ; Reactive Oxygen Species ; Redox Signaling ; Redox TherapeuticsJournal Articlemedicinemedia_common.cataloged_instanceAnimalsHumans[CHIM]Chemical SciencesEuropean UnionEuropean unionNITRIC-OXIDE SYNTHASETANDEM MASS-SPECTROMETRYMolecular BiologyMITOCHONDRIAL OXIDATIVE STRESSGROWTH-FACTOR-BETAOrganic ChemistryDisease progressionBiology and Life SciencesOxidation reductionManganese Superoxide Dismutase030104 developmental biologylcsh:Biology (General)Oxidative stressReactive oxygen species030217 neurology & neurosurgeryOxidative stressRedox biology
researchProduct

New insights into the pathogenesis of giant cell arteritis

2017

Giant cell arteritis (GCA) is an inflammatory chronic disease occurring exclusively in elderly individuals. Until recently, the disease has been considered a unique disease resulting from the interaction in the walls of susceptible arteries, between an unknown infectious agents with local dendritic cells (DCs), activated CD4 T cells and effector macrophages. Recent evidence has shown that this view was too simplistic and has clarified many of the pathogenetic aspects of the disease. Many genetic studies recently published have identified different new genes, including cytokines, adhesion molecules and regulators of innate immunity, as crucial players in the development and progression of GC…

030203 arthritis & rheumatology0301 basic medicineImmunology and Allergy; ImmunologyInnate immune systemGiant Cell ArteritisImmunologyContext (language use)DiseaseBiologymedicine.diseasePathogenesisSettore MED/16 - Reumatologia03 medical and health sciencesGiant cell arteritis030104 developmental biology0302 clinical medicineImmune systemLymphatic systemAntigenImmunologymedicineAnimalsHumansImmunology and Allergyskin and connective tissue diseases
researchProduct

Physiopathologie des vascularites primitives des gros vaisseaux

2016

Giant cell arteritis (GCA) and Takayasu's arteritis (TA) are two granulomatous vasculitis affecting large arteries that present specific epidemiological and clinical features. Their pathogenesis is not fully understood but major advances have been obtained during the last years, thus allowing the emergence of new therapeutic strategies. GCA and TA develop on a specific genetic background but share some similarities regarding the immunological pathways involved in their pathogenesis. The trigger of these diseases is not clearly identified but it is thought that an infectious agent could activate and lead to the maturation of dendritic cells that are localized in the adventitia of arteries. T…

030203 arthritis & rheumatology0301 basic medicineTakayasu's arteritisGastroenterologyBiologymedicine.diseasePathogenesis03 medical and health sciencesGiant cell arteritis030104 developmental biology0302 clinical medicinemedicine.anatomical_structureImmune systemGiant cellAdventitiaImmunologyInternal MedicinemedicineCytotoxic T cellcardiovascular diseasesArteritisLa Revue de Médecine Interne
researchProduct

Giant cell arteritis (Horton's disease) in very elderly patients aged 80 years and older: A study of 25 cases

2015

Aim Analysis of the characteristics of very elderly patients with giant cell arteritis (GCA). Methods Patients aged 80 years and older diagnosed with GCA in our department between 1 January 2002 and 31 July 2008 were retrospectively included. For each patient, we recorded general characteristics, reason(s) for hospitalization, specialty of the physician or department that referred the patient to us, medical history, treatment at admission, GCA clinical features, time to diagnosis of GCA, biological screening and GCA treatment. Results We analyzed 25 clinical records, 18 women and seven men with a mean age of 83.9 years. General weakness, visual loss and inflammatory syndrome were the princi…

030203 arthritis & rheumatologyWeaknessPediatricsmedicine.medical_specialtyeducation.field_of_studymedicine.diagnostic_testbusiness.industryPopulationSpecialtyDiseasemedicine.diseaseSurgeryVery frequent030207 dermatology & venereal diseases03 medical and health sciencesGiant cell arteritis0302 clinical medicineBiopsymedicineMedical historymedicine.symptombusinesseducationGeriatrics & Gerontology International
researchProduct

Recurrent strokes associated with uncontrollable giant cell arteritis

2016

International audience

030203 arthritis & rheumatologymedicine.medical_specialtybusiness.industry[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiologymedicine.disease03 medical and health sciencesGiant cell arteritis0302 clinical medicineNeurologyRecurrent stroke[ SDV.NEU.NB ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyStrokesmedicineNeurology (clinical)Radiologybusiness030217 neurology & neurosurgeryComputingMilieux_MISCELLANEOUSGiant cell arteritis
researchProduct

Multi-variate analysis predicts clinical outcome 30 days after middle cerebral artery infarction

2000

BACKGROUND AND PURPOSE: To evaluate the functional prognostic value of proton magnetic resonance spectroscopy performed within the 5 days of an infarction of the middle cerebral artery territory, compared with previously demonstrated prognostic factors. METHODS: Proton magnetic resonance spectroscopy was performed on 77 consecutive non-comatosed patients during the acute stage of middle cerebral artery infarction. The functional status was determined for each patient via the Orgogozo score. Proton magnetic resonance spectroscopic data were acquired in the infarction and in contra-lateral normal tissue and the results were expressed as metabolite ratios. Correlations were evaluated between t…

0303 health sciencesmedicine.medical_specialtyMulti variate analysisbusiness.industryCerebral infarctionVascular diseaseInfarctionGeneral Medicinemedicine.diseaseSurgeryCentral nervous system disease03 medical and health sciences0302 clinical medicineNeurologymedicine.arteryInternal medicineMiddle cerebral arteryMiddle Cerebral Artery InfarctionmedicineCardiologyFunctional statusNeurology (clinical)business030217 neurology & neurosurgery030304 developmental biologyActa Neurologica Scandinavica
researchProduct

2015

Background Atrial fibrillation (AF), whether silent or symptomatic, is a frequent and severe complication of acute myocardial infarction (AMI). Asymmetric dimethylarginine (ADMA), an endogenous eNOS inhibitor, is a risk factor for endothelial dysfunction. We addressed the relationship between ADMA plasma levels and AF occurrence in AMI. Methods 273 patients hospitalized for AMI were included. Continuous electrocardiographic monitoring (CEM) ≥48 hours was recorded and ADMA was measured by High Performance Liquid Chromatography on admission blood sample. Results The incidence of silent and symptomatic AF was 39(14%) and 29 (11%), respectively. AF patients were markedly older than patients wit…

0303 health sciencesmedicine.medical_specialtyMultidisciplinaryEjection fractionbusiness.industryAtrial fibrillation030204 cardiovascular system & hematologymedicine.disease3. Good healthCoronary artery disease03 medical and health scienceschemistry.chemical_compound0302 clinical medicinechemistryHeart failureInternal medicineHeart ratemedicineCardiologyMyocardial infarctionEndothelial dysfunctionAsymmetric dimethylargininebusiness030304 developmental biologyPLOS ONE
researchProduct

Is «Social language variation» an operational category for language corpus planning?

2019

Hem constatat les dificultats d’aprofundir les relacions conceptuals entre la variació social i la funcional, que comencen quan ens preguntem quins factors socials són pertinents per descriure el col·loquial. Creiem que cal tenir en compte, en ordre decreixent, les «adscripcions identitàries» que Block (2014) analitza: capital lingüístic, capital cultural, edat, gènere, activitat habitual, «habitus/ideologia/actituds», «classe social», ètnia i religió. En aquest context d’incertesa conceptual, no és estrany que la variació social sigui una dimensió sociolingüística tractada inadequadament en la normativa catalana: Badia (1994) confon els termes diastràtic i diafàsic i llegint els textos nor…

050101 languages & linguisticsLinguistics and LanguageUNESCO::CIENCIAS DE LAS ARTES Y LAS LETRASVariació social05 social sciences050301 educationLanguage corpus planificationLanguage and LinguisticsVariació funcionalGeographic language variationEstandardització lingüísticaSocial language variationPlanificació lingüística de corpusFunctional language variationLanguage standardisation:CIENCIAS DE LAS ARTES Y LAS LETRAS [UNESCO]Codificació lingüísticaVariació geogràfica0501 psychology and cognitive sciencesInstitut d’Estudis Catalans0503 educationLanguage codification
researchProduct